Seres Therapeutics Inc 's

• MCRB's Stock Performance relative to its Competitors

Aprea Therapeutics Inc Share Performance +4.21% This Quarter

Aprea Therapeutics Inc Profile Aprea Therapeutics Inc is a biopharmaceutical company with a business model focused on developing and commercializing innovative cancer therapies. They aim to leverage their proprietary discovery platform to identify and develop small molecules that selectively target and restore the tumor suppressor protein p53. Their business strategy includes conducting clinical trials, seeking regulatory approvals, and partnering with other organizations for commercialization and distribution. More about Aprea Therapeutics Inc 's Market Share

2seventy Bio Inc Share Performance +68.92% This Year

2seventy Bio Inc Profile 2seventy Bio Inc operates on a business model centered around the development and commercialization of innovative genetic therapies. They strive to harness the power of biotechnology to address complex diseases and improve patient outcomes. By advancing their proprietary gene delivery technologies and collaborating with industry partners, they aim to create scalable treatments that revolutionize the field of genetic medicine. More about 2seventy Bio Inc 's Market Share

Sources: Seres Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 4:33 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Seres Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.